Why the study?
Does primary ICD therapy result in appropriate device discharges in patients with unexplained syncope, structural heart disease, and inducible sustained monomorphic VT?
Does primary ICD therapy result in appropriate device discharges in patients with unexplained syncope, structural heart disease, and inducible sustained monomorphic VT?
Patients with unexplained syncope, structural heart disease, and inducible VT have high rates of subsequent tachyarrhythmic events, supporting the use of primary ICD therapy in this population.
No takes yet. Share an insight, caveat, or question.
Supports primary ICD consideration in this high-risk group; leaves open need for randomized confirmation.
Menon et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: